Pilot Compassionate Use Study of Thioctic Acid Treatment in Mitochondrial Myopathy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00004770|
Recruitment Status : Completed
First Posted : February 25, 2000
Last Update Posted : June 24, 2005
I. Assess the efficacy of thioctic acid in treating a single patient with mitochondrial myopathy.
|Condition or disease||Intervention/treatment||Phase|
|Mitochondrial Myopathy||Drug: thioctic acid||Not Applicable|
PROTOCOL OUTLINE: The patient receives one thioctic acid tablet 3 times a day. If patient experiences no side effects after 1 week, 2 tablets are administered and given 3 times a day over 3 months for compassionate use.
The patient is followed at weeks 3, 8, and 12.
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||1 participants|
|Study Start Date :||October 1995|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00004770
|Study Chair:||Robert Griggs||University of Rochester|